Alnylam Advances New Innovations in RNAi Therapeutics
Go back to Alnylam Advances New Innovations in RNAi Therapeutics| Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) | Delayed: 231.89 -10.72 (4.42%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $242.61 | 52 Week High | $109.10 | |||
| Open | $239.00 | 52 Week Low | $31.38 | |||
| Day High | $240.88 | P/E | N/A | |||
| Day Low | $231.72 | EPS | $-1.45 | |||
| Volume | 934,341 | |||||
| Kirin Holdings Company, Limited Sponsored ADR (AMEX: KNBWY) | Delayed: 19.13 +0.15 (0.79%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $18.98 | 52 Week High | $18.64 | |||
| Open | $19.08 | 52 Week Low | $12.59 | |||
| Day High | $19.19 | P/E | N/A | |||
| Day Low | $19.08 | EPS | $0.00 | |||
| Volume | 6,216 | |||||
